StockData
CareDx, Inc. logo

CareDx, Inc. (CDNA) income statement

CDNANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 12/3026% above fair value
$74.44−0.12 (-0.16%)

Close on Nov 18, 2026Market cap $3.91BP/E 31.1Yield –

CareDx, Inc. income statement

Ratios

Latest available, balances at Sep 30, 2026

Profitability, TTM

Gross margin
–
Operating margin
23.4%
Net margin
25.9%
Return on equity, FY2025
-6.3%

Financial strength

Current ratio
2.31
Debt to equity
–
Debt to assets
–
Cash to current liabilities
180.2%

Valuation

P/E ratio
31.1
Price to sales
7.86
Price to book
8.37
Dividend yield
–

See a number that looks wrong?